Skip to main content
Division of Cardiovascular Medicine Division of Cardiovascular Medicine

Publications

Names of current and past lab members are underlined and bolded. Free articles are linked in the titles.

Published Articles in Peer Reviewed Journals Arranged by Topic

Epicatechin's effect on skeletal muscle and mitochondrial function

  1. Yamazaki KG, Taub PR, Barraza-Hidalgo M, Rivas MM, Zambon AC, Ceballos G, Villarreal FJ. Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J Am Coll Cardiol. 2010;55(25):2869-76 (PMID: 20579545, PMCID: PMC2915587).
  2. Nogueira L, Ramirez-Sanchez I, Perkins GA, Murphy A, Taub PR, Ceballos G, Villarreal FJ, Hogan MC, Malek MH. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol. 2011;589(Pt 18):4615-31 (PMID: 21788351, PMCID: PMC3208228).
  3. Taub PR, Ramirez-Sanchez I, Ciaraldi TP, Perkins G, Murphy AN, Naviaux R, Hogan M, Maisel AS, Henry RR, Ceballos G, Villarreal F. Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa. Clin Transl Sci. 2012;5(1):43-7 (PMID: 22376256, PMCID: PMC5439909).
  4. Ramirez-Sanchez I, Nogueira L, Morena A, Murphy A, Taub PR, Perkins G, Ceballos G, Hogan M, Malek MH, Villarreal F. Perturbations in skeletal muscle sarcomere structure in patients with heart failure and type 2 diabetes: restorative effects of (-)-epicatechin-rich cocoa. J Cardiovasc Pharmacol. 2012;60:429-38 (PMID: 22833114, PMCID: PMC3496054).
  5. Ramirez-Sanchez I, Taub PR, Ciaraldi TP, Nogueira L, Coe T, Perkins G, Hogan M, Maisel AS, Henry RR, Ceballos G, Villarreal F. (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. Int J Cardiol. 2013;168(4):3982-90 (PMID: 23870648, PMCID: PMC3805662).
  6. Taub PR, Ramirez-Sanchez I, Ciaraldi T, Gonzalez-Basurto S, Coral-Vazquez R, Perkins G, Hogan M, Maisel A, Henry R, Ceballos G, Villarreal F. Severe perturbations in skeletal muscle sarcomere structure of heart failure and type 2 diabetes patients: Restorative effects of (-)-epicatechin-rich cocoa. Clin Sci. 2013;125:383-89 (PMID: 23642227, PMCID: PMC3805662).
  7. Gutierrez-Salmean G, Ciaraldi T, Nogueira L, Taub PR, Hogan M, Henry R, Meany E, Villarreal F, Ceballos G, Ramirez-Sanchez I. Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. J Nut Biochem. 2013;25:91-4 (PMID: 2431487, PMCID: PMC3857584).
  8. Ortiz-Vilchis P, Yamazaki KG, Rubio-Gayosso I, Ramirez-Sanchez I, Calzada C, Romero-Perez D, Ortiz A, Meaney E, Taub PR, Villarreal F, Ceballos G. Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling. Eur J Pharmacol. 2014;744:76-82 (PMID: 25281837, PMCID: PMC5109834).
  9. Barnett CF, Moreno-Ulloa A, Shiva S, Ramirez-Sanchez I, Taub PR, Su Y, Ceballos G, Dugar S, Schreiner G, Villarreal F. Pharmacokinetic, partial pharmacodynamics and initial safety analysis of (-)-epicatechin in healthy volunteers. Food Funct. 2015;6(3):824-33 (PMID: 25598082, PMCID: PMC4357542).
  10. Taub PR, Ramirez-Sanchez I, Patel M, Higginbotham E, Moreno-Ulloa A, Roman L, Phillips P, Ceballos G, Villareal F. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: Underlying mechanisms. A double blind, randomized, placebo-controlled trial.  Food Funct. 2016;7(9):3686-93. (PMID: 27491778, PMCID: PMC5025384).
  11. Gutierrez-Salmean G, Meany E, Lanaspa MA, Cicerchi C, Johnson RJ, Dugar S, Taub PR, Ramirez-Sanchez I, Villarreal F, Schreiner G, Ceballos G. A randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: unique in vitro effects. Int J Cardiol. 2016; 223:500-506 (PMID: 27552564).
  12. Formentini L, Ryan AJ, Gálvez-Santisteban M, Carter L,Taub P, Lapek JD Jr, Gonzalez DJ, Villarreal F, Ciaraldi TP, Cuezva JM, Henry RR.  Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance.  Diabetologia. 2017;60(10):2052-2065 (PMID: 28770317, PMCID: PMC6572787).
  13. Moreno-Ulloa A, Nájera-García N, Hernández M, Ramírez-Sánchez I, Taub PR, Su Y, Beltrán-Partida E, Ceballos G, Dugar S, Schreiner G, Best BM, Ciaraldi TP, Henry RR, Villarreal F. A pilot study on clinical pharmacokinetics and preclinical pharmacodynamics of (+)-epicatechin on cardiometabolic endpoints. Food Funct. 2018;9(1):307-319 (PMID: 29171848, PMCID: PMC5783763).

Cardiometabolic Effects of Time-Restricted Eating

  1. Sulli G, Manoogian ENC, Taub PR, Panda S. Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases. Trends Pharmacol Sci. 2018:pii: S0165-6147(18)30119-6 (PMID: 30060890).
  2. Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab. 2020;31(1):92-104.e5 (PMID: 31813824; PMCID: PMC6953486).
  3. Dong TA, Sandesara PB, Dhindsa DS, Mehta A, Arneson LC, Dollar AL, Taub PR, Sperling LS. Intermittent Fasting: A Heart Healthy Dietary Pattern? Am J Med. 2020; S0002-9343(20)30335-1 (PMID: 32330491).
  4. Świątkiewicz I, Woźniak A, Taub PR. Time-Restricted Eating and Metabolic Syndrome: Current Status and Future Perspectives. 2021;13(1):221 (PMID: 33466692).
  5. Świątkiewicz I, Mila-Kierzenkowska C, Woźniak A, Szewczyk-Golec K, Nuszkiewicz J, Wróblewska J, Rajewski P, Eussen SJPM, Færch K, Manoogian ENC, Panda S, Taub PR. Pilot Clinical Trial of Time-Restricted Eating in Patients with Metabolic Syndrome. 2021 Jan 24;13(2):346. PMID: 33498955.
  6. Manoogian ENC, Zadourian A, Lo HC, Gutierrez NR, Shoghi A, Rosander A, Pazargadi A, Wang X, Fleischer JG, Golshan S, Taub PR, Panda S. Protocol for a randomised controlled trial on the feasibility and effects of 10-hour time-restricted eating on cardiometabolic disease risk among career firefighters doing 24-hour shift work: the Healthy Heroes Study. BMJ Open. 2021;11(6):e045537 (PMID: 34135038).
  7. Manoogian EN, Chow LS, Taub PR, Laferrère B, Panda S. Time-restricted eating for the prevention and management of metabolic diseases. Endocr Rev. 2022;43(2):405-436. (PMID: 34550357).
  8. Taub PR, Panda S. Time for better time-restricted eating trials to lessen the burden of metabolic diseases. Cell Rep Med. 2022 21;3(6):100665. PMID: 35732151.
  9. Manoogian ENC, Zadourian A, Lo HC, Gutierrez NR, Shoghi A, Rosander A,  Pazargadi A,  Ormiston CK, Wang X,  Sui J, Hou Z, Fleischer JG, Golshan S, Taub PR, and Panda S.  Feasibility of Time-Restricted Eating and Impacts on Cardiometabolic Health in 24-Hour Shift Workers: The Healthy Heroes Randomized Clinical Trial. Cell Metab. 2022 October 4; In Press.

Dysautonomia/Postural Orthostatic Tachycardia Syndrome (POTS)

  1. Zadourian A, Doherty TA, Świątkiewicz I, and Taub PR. Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management. 2018; 78(10):983-994 (PMID: 29943373).
  2. Taub PR, Zadourian A, Lo H, Ormiston C, Golshan S, Hus JC. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia. J Am Coll Cardiol. 2021;77:861–7  (PMID: 33602468).
  3. Taub PR, Zadourian A, Hsu JC. Reply: Ivabradine in POTS: Increase in Central Pressure Rather Than Down-Regulation of Sympathetic Nervous System. J Am Coll Cardiol. 2021 Jun 22;77(24):3142-3143. PMID: 34140117.
  4. Ocher RA, Padilla E, Hsu JC, Taub PR. Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection. Case Rep Cardiol. 2021 Aug 18;2021:7809231. PMID: 34471549.
  5. Mittal N, Portera A, Taub P. Improvement of hyperadrenergic postural orthostatic tachycardia syndrome (POTS) with methylated B vitamins in the setting of a heterozygous COMT Val158Met polymorphism. BMJ Case Rep. 2021 Nov 11;14(11):e245012. PMID: 34764114.
  6. Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, Baggish AL, Bozkurt B, Cornwell WK 3rd, Harmon KG, Kim JH, Lala A, Levine BD, Martinez MW, Onuma O, Phelan D, Puntmann VO, Rajpal S, Taub PR, Verma AK. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee.  J Am Coll Cardiol. 2022 Mar; 14:S0735-1097.
  7. Ormiston CK, Padilla E, Van DT, Boone C, You S, Roberts AC, Hsiao A, Taub PR. May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case series. Eur Heart J Case Rep. 2022 (PMID: 35620060).
  8. Ormiston CK, Świątkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022 Jul 16:S1547-5271(22)02185-3. (PMID: 35853576).

Biomarkers

  1. Ko N, Rajendran PR, Kim H, Rutowski M, Pawlikowska L, Kowk P, Higashida R, Lawton M, Smith W, Zaroff J, Young W. Endothelial nitric oxide synthase polymorphism and risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. 2008;39(4):1103-8 (PMID: 18309169, PMCID: PMC2650384).
  2. Taub PR, Daniels LB, Maisel AS. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation. Heart Fail Clin. 2009;5(2):169-75 (PMID: 19249686).
  3. Taub PR, Gabbai-Saldate P, Maisel A. Biomarkers of heart failure. Congest Heart Fail. 2010;16 Suppl 1:S19-24 (PMID: 20653707).
  4. Taub PR, Fields J, Wu AH, Miss J, Lawton M, Smith WS, Young WL, Zaroff JG, Ko NU. Elevated BNP is Associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage. Neurocritical Care 2011;15:13-18. (PMID: 21479679, PMC3133817).
  5. Xue Y, Taub PR, Fard A, Maisel AS. Hypervolemic and optivolemic natriuretic peptides in acute heart failure. Contrib Nephrol 2011;171:74-9. (PMID: 21625093).
  6. Xue Y, Taub PR, Iqbal N, Fard A, Wentworth B, Redwine L, Clopton P, Stein M, Maisel A. Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. Am J Cardiol. 2012;109(8):1215-8 (PMID: 22305506).
  7. Taub PR, Borden KC, Fard A, Maisel A. Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome. Expert Rev Cardiovasc Ther. 2012;10(5):657-67 (PMID: 22651841, PMCID: PMC4060800).
  8. Prasain JK, Arabshahi A, Taub PR, Sweeney S, Moore R, Sharer JD, Barnes S. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;913-914:161-8 (PMID: 23314354, PMDIC: PMC3779072).
  9. Wentworth BA, Stein MB, Redwine LS, Xue Y, Taub PR, Clopton P, Nayak KR, Maisel AS. Post-traumatic stress disorder: a fast track to premature cardiovascular disease? Cardiol Rev. 2013;21(1):16-22 (PMID: 22717656).
  10. Xue Y*, Taub PR*, Iqbal N, Fard A, Clopton P, Maisel A. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure. Eur J Heart Fail 2013;15:1343-9 (PMID: 23887059). *co-first author
  11. Maisel A, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Borden K, Iqbal N, Taub PR, Kupfer K, Clopton P, Greenberg B. Primary results of the HABIT Trial (heart failure assessment with BNP in the home). J Am Coll Cardiol. 2013;61(16):1726-35 (PMID: 23500322).
  12. Tokman S, Barnett CF, Jarlsberg LG, Taub PR, den Boon S, Davis JL, Cattamanchi A, Worodria W, Maisel A, Huang L. International HIV-Associated Opportunistic Pneumonias (IHOP) Study Group. Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections. 2014 Apr;19(3):382-8 (PMID: 24460728, PMCID: PMC4276722).
  13. Shah KS, Taub PR, Patel M, Rehfeldt M, Struck J, Clopton P, Mehta RL, Maisel AS. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol. 2015;83(1):29-35 (PMID: 25512100).
  14. Maisel AS, Shah KS, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Iqbal N,Taub PR, Kupfer K, Lee E, Clopton P, Zile M, Greenberg B. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial. J Card Fail. 2016;22(4):283-93 (PMID: 26433086).
  15. Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. J Am Coll Cardiol. 2016; 68(13):1420-31 (PMID: 27659464).
  16. Świątkiewicz I, Taub PR. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure. Kardiol Pol. 2018;76(5):821-829 (PMID: 29633232).
  17. Murray PT, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Horiuchi Y, Clopton P, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A. Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary findings for urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic heart failure Study (AKINESIS). J Card Fail. 2019;25(8):654-665 (PMID: 31128242).
  18. Wettersten N, Horiuchi Y, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT, Maisel A. B-type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure. Eur J Heart Fail. 2019;21(12):1553-1560 (PMID: 31769140).
  19. Wettersten N, Horiuchi Y, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A, Murray PT. Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study. Eur J Heart Fail. 2020 Feb;22(2):251-263 (PMID: 31863682).
  20. Świątkiewicz I, Magielski P, Kubica J, Zadourian A, DeMaria AN, Taub PR. Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure. Int J Mol Sci. 2020;21(3):807. PMID: 31991903.
  21. Horiuchi Y, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A, Murray PT. Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure. Am J Cardiol. 2021; (PMID: 33617811).
  22. Horiuchi YU, Wettersten N, Veldhuisen DJV, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDONALD K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A, Murray PT. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure. J Card Fail. 2021 May;27(5):533-541. PMID: 33296713.
  23. Horiuchi Y, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Duff S, Maisel A, Murray PT. Decongestion, kidney injury and prognosis in patients with acute heart failure. Int J Cardiol. 2022 Feb 21:S0167-5273(22)00261-3. PMID: 35202737.

Other Publications in Chronological Order

  1. Scarrow A, Rajendran PR, William Welch. Glioblastoma multiforme of the conus medullaris. Clin Neurol Neurosurg. 2000;102:166-9 (PMID: 10996716).
  2. Scarrow A, Rajendran PR, Donald M. Metastatic prostate adenocarcinoma of the dura mater. Br J Neurosurg. 2000;14:473-5 (PMID: 11198774).
  3. Hersh BP, Rajendran PR, Battinelli D, Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology. 2001;56:278-9 (PMID: 11160977).
  4. Rajendran PR. The internet: ushering in a new era of medicine. 2001;285:804 (PMID: 11176920).
  5. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson’s disease. 2001;57:790-4 (PMID: 11552005).
  6. Rajendran PR. Ethical issues involved in disclosing medical errors. 2001;286(9):1078 (PMID: 11559295).
  7. Rajendran PR, Molitor J. Resolution of hypertensive encephalopathy and scleroderma renal crisis with an angiotensin receptor blocker. J Clin Rheumatol. 2005;11:205-8 (PMID: 16357757).
  8. Yarlagadda S. Rajendran PR, Miss J, Banki N, Kopelnik A, Ko N, Gelb A, Lawton M, Smith W, Young W, Zaroff J. Cardiovascular predictors of inpatient mortality after subarachnoid hemorrhage. Neurocrit Care. 2006;5(2):102-7 (PMID: 17099255).
  9. Taub PR, Higginbotham E, Henry RR. Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes. Curr Cardiol Rep. 2013:2:332 (PMID: 23314689).
  10. Higginbotham E, Taub PR.  Cardiovascular benefits of dark chocolate?  Curr Treat Options Cardiovasc Med. 2015;(12):54 (PMID: 26456559).
  11. Aggarwal M, Devries S, Freeman AM, Ostfeld R, Gaggin H, Taub P, Rzeszut AK, Allen K, Conti RC. The Deficit of Nutrition Education of Physicians. Am J Med. 2018;131(4):339-345 (PMID: 29269228).
  12. Henry RR, Müller-Wieland D, Taub PR, Bujas-Bobanovic M, Louie MJ, Letierce A, Ginsberg HN. Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials. Diabetes Obes Metab. 2018;20(7):1632-1641 (PMID: 29493859).
  13. Freeman AM, Taub PR, Lo HC, Ornish D. Intensive Cardiac Rehabilitation: an Underutilized Resource. Curr Cardiol Rep. 2019;21(4):19 (PMID: 30828747).
  14. Modestino AE, Skowronski EA, Pruitt C, Taub PR, Herbst K, Schmid-Schönbein GW, Heller MJ, Mills PJ. Elevated Resting and Postprandial Digestive Proteolytic Activity in Peripheral Blood of Individuals With Type-2 Diabetes Mellitus, With Uncontrolled Cleavage of Insulin Receptors. J Am Coll Nutr. 2019; 38(6):485-492 (PMID: 30964398).
  15. Mills PJ, Taub PR, Lunde O, Pung MA, Wilson K, Pruitt C, Rutledge T, Maisel A, Greenberg BH. Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus. Clin Cardiol. 2019;42(6):637-643 (PMID: 31017303, PMCID: PMC6553353).
  16. Sands BE, Taub PR, Armuzzi A, Friedman GS, Moscariello M, Lawendy N, Pedersen RD, Chan G, Nduaka CI, Quirk D, Salese L, Su C, Feagan BG. Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Jan;18(1):123-132.e3. PMID: 31077827.
  17. Wilkinson MJ, Zadourian A, Taub PR. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship. Am J Card. 2019; 124(1):S3-S11 (PMID: 31741438).
  18. Saiz J, Pung MA, Wilson KL, Pruitt C, Rutledge T, Redwine L, Taub PR, Greenberg BH, Mills PJ. Is Belonging to a Religious Organization Enough? Differences in Religious Affiliation Versus Self-ratings of Spirituality on Behavioral and Psychological Variables in Individuals With Heart Failure. Healthcare (Basel). 2020;8(2):E129 (PMID: 32397220).
  19. Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, Navar AM, Taub PR, Toth PP, Virani SS, Wong ND, Shapiro MD. Continuity of Care and Outpatient Management for Patients with and at High Risk for Cardiovascular Disease during the COVID-19 Pandemic: A Scientific Statement from the American Society for Preventive Cardiology. American Journal of Preventive Cardiology. 2020:100009 (PMCID: PMC7194073).
  20. D'Souza MS, Dong TA, Ragazzo G, Dhindsa DS, Mehta A, Sandesara PB, Freeman AM, Taub P, Sperling LS. From Fad to Fact: Evaluating the Impact of Emerging Diets on the Prevention of Cardiovascular Disease. Am J Med. 2020 Oct;133(10):1126-1134. Epub 2020 Jun 19. Review. (PMID: 32569590).
  21. Hsu JC, Darden D, Alegre M, Birgersdotter-Green U, Feld GK, Hoffmayer KS, Han F, Krummen D, Raissi F, Ho G, Taub PR, Urey MA, Adler E. Effect of closed loop stimulation versus accelerometer on outcomes with cardiac resynchronization therapy: the CLASS trial. J Interv Card Electrophysiol. 2021 Sep;61(3):479-485. PMID: 32757086.
  22. Sands BE, Colombel JF, Ha C, Farnier M, Armuzzi A, Quirk D, Friedman GS, Kwok K, Salese L, Su C, Taub PR. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflamm Bowel Dis. 2021 May 17;27(6):797-808. PMID: 32870265.
  23. Chindhy S, Taub PR, Lavie CJ, Shen J. Current challenges in cardiac rehabilitation: strategies to overcome social factors and attendance barriers. Expert Rev Cardiovasc Ther. 2020 Sep 14;:1-13. (PMID: 32885702).
  24. McCormick D, Bhatt DL, Bays HE, Taub PR, Caldwell KA, Guerin CK, Steinhoff J, Ahmad Z, Singh R, Moreo K, Carter J, Heggen CL, Sapir T. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model. J Manag Care Spec Pharm. 2020 Dec;26(12):1517-1528. (PMID: 33251993).
  25. Atar D, Jukema, J, Molemans B, Taub PR, Goto S, Mach F, CerezoOlmos C, Underberg J, Keech A, Tokgozoglu L, Bonaca M. New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? 2021 (PMID: 33476944).
  26. Epstein E, Rosander A, Pazargadi A, Taub P. Cardiac Rehab for Functional Improvement. Curr Heart Fail Rep. 2020 Aug;17(4):161-170. (PMID: 32514659).
  27. Mkrtchyan GV, Abdelmohsen K, Andreux P, Bagdonaite I, Barzilai N, Brunak S, Cabreiro F, de Cabo R, Campisi J, Cuervo AM, Demaria M, Ewald CY, Fang EF, Faragher R, Ferrucci L, Freund A, Silva-García CG, Georgievskaya A, Gladyshev VN, Glass DJ, Gorbunova V, de Grey A, He WW, Hoeijmakers J, Hoffmann E, Horvath S, Houtkooper RH, Jensen MK, Jensen MB, Kane A, Kassem M, de Keizer P, Kennedy B, Karsenty G, Lamming DW, Lee KF, MacAulay N, Mamoshina P, Mellon J, Molenaars M, Moskalev A, Mund A, Niedernhofer L, Osborne B, Pak HH, Parkhitko A, Raimundo N, Rando TA, Rasmussen LJ, Reis C, Riedel CG, Franco-Romero A, Schumacher B, Sinclair DA, Suh Y, Taub PR, Toiber D, Treebak JT, Valenzano DR, Verdin E, Vijg J, Young S, Zhang L, Bakula D, Zhavoronkov A, Scheibye-Knudsen M. ARDD 2020: from aging mechanisms to interventions. Aging (Albany NY). 2020 Dec 30;12(24):24484-24503. PMID: 33378272.
  28. Epstein E, Patel N, Maysent K, Taub PR. Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities. Curr Cardiol Rep. 2021. PMID: 33704611.
  29. Epstein E, Maisel S, Maysent K, Taub PR. Cardiac rehabilitation for coronary artery disease: latest updates. Curr Opin Cardiol. 2021 Sep 1;36(5):556-564. PMID: 34397462.
  30. Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses. 2021. PMID: 34071557.
  31. Aroda VR, Taub PR, Stanton AM. Diabetes With Cardiomyopathy: At the Juncture of Knowledge and Prevention. J Am Coll Cardiol. 2021 Oct 19;78(16):1599-1602. PMID: 34649697.
  32. Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 2021 Jan 23;5:100149. PMID: 34327491.
  33. Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2021 Dec 7:108101. Epub ahead of print. PMID: 34922811.
  34. Xu I, Taub PR. Baseline testosterone level may modulate statin efficacy. Coron Artery Dis. 2021 Dec 1;32(8):713-714. PMID: 33826543.
  35. Świątkiewicz I, Di Somma S, De Fazio L, Mazzilli V, Taub PR. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice. Nutrients. 2021 Oct 29;13(11):3883. PMID: 34836144.
  36. Lee AC, Li WT, Apostol L, Ma J, Taub PR, Chang EY, Rajasekaran M, Ongkeko WM. Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis. Comput Struct Biotechnol J. 2021;19:3755-3764. PMID: 34221254.
  37. Wettersten N, Horiuchi Y, van Veldhuisen DJ, Ix JH, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Duff S, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Maisel A, Murray PT. Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failure. Eur J Heart Fail. 2021 Jul;23(7):1122-1130. PMID: 33788989.
  38. You S, Masutani EM, Alley MT, Vasanawala SS, Taub PR, Liau J, Roberts AC, Hsiao A. Deep Learning Automated Background Phase Error Correction for Abdominopelvic 4D Flow MRI. Radiology. 2021 Nov 30:211270. Epub ahead of print. PMID: 34846200.
  39. Kianoush S, Al Rifai M, Patel J, George J, Gulati M, Taub P, Moran T, Shapiro MD, Agarwala A, Ullah W, Lavie CJ, Bittner V, Ballantyne CM, Virani SS. Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. Prog Cardiovasc Dis. 2022 Feb 16:S0033-0620(22)00021-4. PMID: 35182577
  40. Ormiston CK, Rosander A, Taub PR. Heart-Healthy Diets and the Cardiometabolic Jackpot. Med Clin North Am. 2022 Mar;106(2):235-247. PMID: 35227427
  41. Sykes AV, Patel N, Lee D, Taub PR. Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment. Curr Cardiol Rep. 2022 Aug 24. doi: 10.1007/s11886-022-01775-5. Epub ahead of print. PMID: 36001215.

Textbook

  1. Wilkinson M, Garshick M, Taub PR (editors) Nutritional and Dietary Approaches to the Prevention and Treatment of Cardiovascular Disease.  1st ed., Springer.

Book Chapters

  1. Kevin Shah, Pam R. Taub, Alan Maisel (2011).  Biomarkers in acute heart failure.  In:. European Society of Cardiology Textbook of Intensive and Acute Cardiac Care (pp. 335-245).  Oxford: Oxford University Press.
  2. Kabir Singh, Pam R. Taub, Alan Maisel (2011).  Biomarkers.  In: Cardiology Review (pp. 26-36).   New York: McGraw Hill.
  3. Hannah C. Lo, Aryana Pazargadi, Iwona Świątkiewicz, Pam R. Taub (2021). Secondary Prevention and Cardiac Rehabilitation. In ASPC Manual of Preventive Cardiology (pp. 673-703). Cham Switzerland: Springer.
  4. Harpreet Bhatia, Irvin Xu, Pam R Taub, Michael J Wilkinson (2022). Ethnic Factors in the Assessment of Cardiovascular Risk for Primary Prevention. In Cardiovascular Risk Assessment in Primary Prevention, (pp.199-226). Cham Switzerland: Springer.

View the complete list of published works by Dr. Pam Taub in My Bibliography.